Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious... Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. Mehr anzeigen
Immunome to present at the 43rd Annual J.P. Morgan Healthcare Conference. Topline data for Phase 3 RINGSIDE study of varegacestat (formerly known as AL102) expected in second half of 2025. IND...
SAN FRANCISCO and SINGAPORE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat...
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2025...
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on December 2, 2024...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome’s management will...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.37 | -3.57142857143 | 10.36 | 11.06 | 9.24 | 878985 | 10.02837351 | CS |
| 4 | -1.11 | -10 | 11.1 | 11.6 | 9.24 | 852518 | 10.56318218 | CS |
| 12 | -2.11 | -17.4380165289 | 12.1 | 15.125 | 8.97 | 825494 | 11.37961087 | CS |
| 26 | -4.225 | -29.7221245164 | 14.215 | 16.81 | 8.97 | 718289 | 12.70360754 | CS |
| 52 | -3.86 | -27.8700361011 | 13.85 | 30.958 | 8.97 | 795084 | 15.25312562 | CS |
| 156 | -0.31 | -3.00970873786 | 10.3 | 30.958 | 2.09 | 329365 | 13.69299738 | CS |
| 260 | -5.67 | -36.2068965517 | 15.66 | 63.78 | 2.09 | 290120 | 15.54823707 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
